{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T01:04:03Z","timestamp":1784423043140,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T00:00:00Z","timestamp":1735084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.yebeh.2024.110241","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T08:30:34Z","timestamp":1737189034000},"page":"110241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A multicenter Phase II randomized, placebo-controlled single-blind trial with the SV2A ligand seletracetam in photosensitive epilepsy patients"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6659-2614","authenticated-orcid":false,"given":"Dorothee","family":"Kasteleijn-Nolst Trenit\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-5264","authenticated-orcid":false,"given":"Armel","family":"Stockis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Genton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-1329","authenticated-orcid":false,"given":"Bassel W.","family":"Abou-Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Masnou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9648-8973","authenticated-orcid":false,"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.110241_b0005","article-title":"The unmet need for rapid epileptic seizure termination (REST)","volume":"15","author":"Asnis-Alibozek","year":"2021","journal-title":"Epilepsy Behav Rep"},{"key":"10.1016\/j.yebeh.2024.110241_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nurt.2006.11.014","article-title":"Seletracetam (UCB 44212)","volume":"4","author":"Bennett","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.yebeh.2024.110241_b0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0013-4694(86)90060-X","article-title":"Photosensitivity as a model for acute antiepileptic drug studies","volume":"63","author":"Binnie","year":"1986","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2024.110241_b0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fncel.2015.00125","article-title":"Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations","volume":"9","author":"Correa-Basurto","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2024.110241_b0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/epi.14701","article-title":"A single-center, open-label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers","volume":"60","author":"Finnema","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110241_b0030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/epi.17175","article-title":"Visually sensitive seizures: an updated review by the Epilepsy Foundation","volume":"63","author":"Fisher","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110241_b0035","doi-asserted-by":"crossref","first-page":"e1786","DOI":"10.1212\/WNL.0000000000007271","article-title":"Photosensitive epilepsy: robust clinical efficacy of a selective GABA potentiator","volume":"92","author":"Gurrell","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.110241_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.eplepsyres.2016.11.012","article-title":"The 'Photosensitivity Model' is (also) a model for focal (partial) seizures","volume":"133","author":"Kasteleijn-Nolst Trenit\u00e9","year":"2017","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.110241_b0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.eplepsyres.2016.02.003","article-title":"Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients: a placebo-controlled pilot study","volume":"122","author":"Kasteleijn-Nolst Trenit\u00e9","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.110241_b0050","doi-asserted-by":"crossref","first-page":"e559","DOI":"10.1212\/WNL.0000000000007894","article-title":"Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)","volume":"93","author":"Kasteleijn-Nolst Trenit\u00e9","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.110241_b0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1212\/01.wnl.0000271385.85302.55","article-title":"Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model","volume":"69","author":"Kasteleijn-Nolst Trenit\u00e9","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2024.110241_b0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0920-1211(96)00031-9","article-title":"Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. evaluation of the piracetam analogue, levetiracetam","volume":"25","author":"Kasteleijn-Nolst Trenit\u00e9","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2024.110241_b0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/14656566.2016.1135129","article-title":"Brivaracetam for the treatment of epilepsy","volume":"17","author":"Klein","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2024.110241_b0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/epi.13340","article-title":"Brivaracetam: rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment","volume":"57","author":"Klitgaard","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110241_b0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s13311-023-01359-3","article-title":"Seizure rescue therapies: comparing approved and commonly used benzodiazepine formulations","volume":"20","author":"Krauss","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.yebeh.2024.110241_b0080","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40263-021-00827-8","article-title":"The pharmacology and clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond","volume":"35","author":"L\u00f6scher","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2024.110241_b0085","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","article-title":"Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond","volume":"30","author":"L\u00f6scher","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2024.110241_b0090","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/cells12091233","article-title":"Animal models of drug-resistant epilepsy as tools for deciphering the cellular and molecular mechanisms of pharmacoresistance and discovering more effective treatments","volume":"12","author":"L\u00f6scher","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.yebeh.2024.110241_b0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1528-1167.2008.01915.x","article-title":"Seletracetam (ucb 44212) inhibits high-voltage-activated Ca2+ currents and intracellular Ca2+ increase in rat cortical neurons in vitro","volume":"50","author":"Martella","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2024.110241_b0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2009.04.024","article-title":"Profile of the new pyrrolidone derivative seletracetam (ucb 44212) in animal models of epilepsy","volume":"614","author":"Matagne","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2024.110241_b0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13550-022-00944-5","article-title":"Drug characteristics derived from kinetic modeling: combined (11)C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A","volume":"12","author":"Naganawa","year":"2022","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.yebeh.2024.110241_b0110","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s40263-020-00761-1","article-title":"Rapidity of CNS effect on photoparoxysmal response for brivaracetam vs. Levetiracetam: a randomized, double-blind, crossover trial in photosensitive epilepsy patients","volume":"34","author":"Reed","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2024.110241_b0115","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.seizure.2014.03.011","article-title":"How predictive are photosensitive epilepsy models as proof of principle trials for epilepsy?","volume":"23","author":"Yuen","year":"2014","journal-title":"Seizure"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024006231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024006231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T23:16:15Z","timestamp":1740698175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024006231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"alternative-id":["S1525505024006231"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110241","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter Phase II randomized, placebo-controlled single-blind trial with the SV2A ligand seletracetam in photosensitive epilepsy patients","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110241"}}